Petros Pharmaceuticals In... (PTPI)
NASDAQ: PTPI
· Real-Time Price · USD
0.03
-0.00 (-10.18%)
At close: Jun 09, 2025, 3:15 PM
Petros Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -14.42M | -14.32M | -4.73M | -7.06M | -8.94M | -8.16M | -12.7M | -21.98M | -21.25M | -20.04M | -24M | -11.87M | -12.17M | -8.99M | -6.24M | -7.84M | -11.49M |
Depreciation & Amortization | 2.19M | 2.94M | 3.21M | 3.27M | 3.34M | 3.42M | 3.4M | 4.13M | 4.86M | 5.6M | 6.37M | 6.54M | 6.71M | 6.88M | 6.86M | 6.8M | 6.73M |
Stock-Based Compensation | -113.13K | 97.22K | 579.95K | 550.79K | 577.27K | 417.23K | 433.34K | 710.63K | 969.58K | 1.2M | 1.09M | 837.73K | 1.22M | 1.31M | 4.37M | 4.64M | 3.97M |
Other Working Capital | -147.71M | -146.74M | -146.43M | 1.09M | 1.57M | 752.72K | -227.62K | 1.45M | -521.04K | -231.14K | -285.02K | -3.16M | -4.08M | -3.67M | -2.8M | -2.61M | -6.64M |
Other Non-Cash Items | 5.92M | 4.15M | -3.45M | 446.14K | 1.95M | 3.58M | 3.68M | -51.86K | -6.55M | -10.42M | -10.5M | -10.46M | -6.55M | -2.5M | -1.92M | -1.18M | 1.87M |
Deferred Income Tax | n/a | n/a | -5.37M | -7.27M | -7.31M | -7.31M | -1.94M | -41.02K | 6.7M | 6.7M | 6.87M | 5.23M | -1.46M | -6.79M | -8.2M | -6.56M | -6.73M |
Change in Working Capital | 2.77M | 4.53M | 3.93M | 1.31M | 2.72M | 789.05K | 556.88K | 5.13M | -466.24K | -3.3M | -6.83M | -9.27M | -4.44M | -1.76M | -2.95M | -5.39M | -7.72M |
Operating Cash Flow | -2.96M | -2.6M | -5.83M | -8.75M | -7.66M | -7.27M | -6.58M | -4.64M | -8.27M | -12.8M | -19.53M | -18.99M | -16.69M | -11.86M | -8.08M | -9.54M | -13.38M |
Capital Expenditures | -24.59K | -24.59K | -19.14K | 2.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.63K | 4.43K | 4.43K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.63M | -4.63M | -4.63M |
Investing Cash Flow | -24.59K | -24.59K | -19.14K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.63M | -4.63M | -4.63M |
Debt Repayment | -765.28K | -765.28K | -1.14M | -1.12M | -1.11M | -1.46M | -1.27M | -1.27M | -1.08M | -1.62M | -3.18M | -4.5M | -5.96M | -7.19M | -7.52M | -3.33M | 3.78M |
Common Stock Repurchased | -23.26K | -1.14M | n/a | -2.7M | -1.12M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -275.17K | n/a | -556.73M | -556.73M | -556.73M | -556.73M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -1.12M | -3.12M | 11.88M | 11.88M | 13M | 15M | n/a | n/a | n/a | 25.76M | 25.76M | 25.76M | 25.76M | 23.07M | 23.07M | 23.02M |
Financial Cash Flow | -5.88M | -7M | -8.23M | 5.64M | 7.23M | 7.99M | 10.18M | -1.27M | -1.08M | -1.62M | 22.58M | 21.26M | 19.8M | 18.57M | 15.55M | 19.74M | 26.8M |
Net Cash Flow | -323.83K | -9.63M | -14.08M | -10.5M | -7.81M | -6.66M | -3.78M | -5.91M | -9.35M | -14.42M | 3.05M | 2.26M | 3.11M | 6.71M | 7.47M | 10.2M | 13.42M |
Free Cash Flow | -2.99M | -2.63M | -5.85M | -8.75M | -7.66M | -7.27M | -6.58M | -4.64M | -8.27M | -12.8M | -19.53M | -18.99M | -16.69M | -11.86M | -8.08M | -9.53M | -13.37M |